US Bancorp’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6K Buy
1,180
+28
+2% +$223 ﹤0.01% 3339
2025
Q4
$6.95K Buy
1,152
+76
+7% +$453 ﹤0.01% 3439
2025
Q3
$6.14K Buy
1,076
+770
+252% +$3.94K ﹤0.01% 3472
2025
Q2
$1.54K Sell
306
-1,231
-80% -$6.6K ﹤0.01% 3904
2025
Q1
$9.96K Buy
1,537
+996
+184% +$8.86K ﹤0.01% 3435
2024
Q4
$3.97K Sell
541
-5,919
-92% -$46.7K ﹤0.01% 3706
2024
Q3
$48.4K Sell
6,460
-1,276
-16% -$11.1K ﹤0.01% 2757
2024
Q2
$68.8K Sell
7,736
-2,604
-25% -$25K ﹤0.01% 2512
2024
Q1
$105K Sell
10,340
-1,069
-9% -$10.9K ﹤0.01% 2340
2023
Q4
$115K Buy
11,409
+9,469
+488% +$86.5K ﹤0.01% 2289
2023
Q3
$18.2K Buy
1,940
+1,170
+152% +$16.7K ﹤0.01% 2930
2023
Q2
$18.9K Buy
770
+25
+3% +$628 ﹤0.01% 3004
2023
Q1
$17.3K Buy
745
+11
+1% +$281 ﹤0.01% 3061
2022
Q4
$18.6K Buy
734
+184
+33% +$4.51K ﹤0.01% 3030
2022
Q3
$10K Sell
550
-432
-44% -$11K ﹤0.01% 3379
2022
Q2
$25K Buy
982
+625
+175% +$14.6K ﹤0.01% 2938
2022
Q1
$9K Buy
357
+66
+23% +$1.96K ﹤0.01% 3428
2021
Q4
$12K Sell
291
-124
-30% -$4.86K ﹤0.01% 3366
2021
Q3
$18K Buy
+415
New +$18K ﹤0.01% 3196
2021
Q1
Sell
-1,500
Closed -$40K 3971
2020
Q4
$40K Hold
1,500
﹤0.01% 2620
2020
Q3
$51K Hold
1,500
﹤0.01% 2391
2020
Q2
$61K Buy
+1,500
New +$50.3K ﹤0.01% 2345

Other funds holding VIR